| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/03/2003 | US20030124123 Also an IL-12 anti-idiotype antibody to the antibody |
| 07/03/2003 | US20030124116 Antibodies binding to polypeptides encoded by the genes |
| 07/03/2003 | US20030124115 A carboxy terminal peptide fragment of thrombopoietin is fused with the carboxy terminal of human erythropoietin; highly enhanced in vivo half-life due to increased carbohydrate content; no antigenicity |
| 07/03/2003 | US20030124113 Human apoptosis associated proteins |
| 07/03/2003 | US20030124105 Programmed cell death genes and proteins |
| 07/03/2003 | US20030124092 IL-17 like molecules and uses thereoflike molecules and uses thereof |
| 07/03/2003 | US20030124056 Carrier molecules |
| 07/03/2003 | CA2486689A1 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 07/03/2003 | CA2471373A1 Modified tridegins, their preparation and their use as transglutaminase inhibitors |
| 07/03/2003 | CA2471160A1 Seminal vesicle tissue-specific promoters and uses thereof |
| 07/03/2003 | CA2471140A1 Antibodies that immunospecifically bind to trail receptors |
| 07/03/2003 | CA2470776A1 Malleable protein matrix and uses thereof |
| 07/03/2003 | CA2470594A1 Leptin proteins |
| 07/03/2003 | CA2469644A1 Method for large scale production of virus antigen |
| 07/03/2003 | CA2453810A1 Mutant proteinase inhibitors and uses thereof |
| 07/02/2003 | EP1324040A2 Direct selection of cells by secretion product |
| 07/02/2003 | EP1323826A1 A cell line expressing mutated human tissue - type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein |
| 07/02/2003 | EP1323824A2 Use of human keratinocyte growth factor-2 for the preparation of pharmaceutical compositions |
| 07/02/2003 | EP1323820A2 Process for facillitated recovery of heterologous proteins from bacterial cells |
| 07/02/2003 | EP1323737A2 Il-3 variant hematopoiesis fusion protein |
| 07/02/2003 | EP1323735A1 Gene relating to drug tolerance and utilization thereof |
| 07/02/2003 | EP1322778A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 07/02/2003 | EP1322769A2 Protein phosphatases |
| 07/02/2003 | EP1322764A2 Method for improved production of cyanophycin and the secondary products thereof |
| 07/02/2003 | EP1322763A2 Listeria inocua , genome and applications |
| 07/02/2003 | EP1322762A2 Haemophilus influenzae antigens and corresponding dna fragments |
| 07/02/2003 | EP1322761A1 A humanized antibody to surface antigen s of hepatitis b virus and a preparing method thereof |
| 07/02/2003 | EP1322760A2 G-protein coupled receptors |
| 07/02/2003 | EP1322759A2 Potassium channel interactors and uses therefor |
| 07/02/2003 | EP1322757A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/02/2003 | EP1322750A2 Proteolysis targeting chimeric pharmaceutical |
| 07/02/2003 | EP1322383A2 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 07/02/2003 | EP1322338A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 07/02/2003 | EP1322284A2 Method for obtaining an active principle with immediate skin-tightening effect and resulting active principle |
| 07/02/2003 | EP1002100B1 Method for producing and identifying new hydrolases having improved properties |
| 07/02/2003 | EP0900025B1 Moraxella catarrhalis outer membrane protein omp106, gene sequence and uses thereof |
| 07/02/2003 | EP0877547A4 Plant glutamate receptors |
| 07/02/2003 | EP0732875B1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 07/02/2003 | EP0731845B1 Homologous recombination antibody expression system for murine cells |
| 07/02/2003 | CN1113101C Process for preparation of substituted aryl lactic acid containing cyclodepsipeptides with 24 ring atoms |
| 07/02/2003 | CN1113096C New stromal cell lines from human bone marrow and their use |
| 07/02/2003 | CN1113068C Materials for production of nanometer structure and use thereof |
| 07/02/2003 | CN1112933C Anti-fungal methods and materials |
| 07/01/2003 | USH2071 Streptococcus pneumoniae gene HI0454 |
| 07/01/2003 | USH2070 Streptococcus pneumoniae gene sequence for DNA ligase |
| 07/01/2003 | US6586578 Deformylase (def1); isolated polynucleotide of given sequence; detects Staphylococcus aureus; can use to screen for antibiotics |
| 07/01/2003 | US6586575 Purification of somatotropin from transformed microorganisms |
| 07/01/2003 | US6586572 Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/01/2003 | US6586397 Polypeptides encoding tyrosine kinase containing immunoglobulin and endithelial growth factor homology domains; induce vascularization |
| 07/01/2003 | US6586396 Subcutaneous administration of natriuretic peptide |
| 07/01/2003 | US6586395 Apoptosis-modulating proteins |
| 07/01/2003 | US6586393 Cyclic peptide antibiotics from Actinomadura sp. of given formula; selective inhibitory activity against E. coli RNA polymerase; use treating infections |
| 07/01/2003 | US6586392 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins |
| 07/01/2003 | US6586242 TAO protein kinases and methods of use therefor |
| 07/01/2003 | US6586236 Modulation of polypeptide display on modified filamentous phage use |
| 07/01/2003 | US6586207 Host cell is a methionine auxotroph; methionine-tRNA synthetase overexpressed in presence of analogues and absence of methionine; protein is modified dihydrofolate reductase |
| 07/01/2003 | US6586206 Methods for making recombinant proteins using apoptosis inhibitors |
| 07/01/2003 | US6586192 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals |
| 07/01/2003 | US6586191 Isolated nucleic acids encoding mammalian galanin receptors, isolated galanin receptor proteins, vectors comprising isolated nucleic acid encoding a mammalian galanin receptor, cells comprising such vectors, antibodies directed to a |
| 07/01/2003 | US6586182 Selecting amino acid sequence variations based on computer modeling; polynucleotides comprising subsequences of nucleic acids encoding the amino acid variations; reassembling into nucleotide sequences encoding mutagenized polypeptides |
| 07/01/2003 | US6586174 Detecting CD8+ by contacting with culture of cells that contain recombinant DNA expression vector in which a reporter gene is associated with promoter sequence; measuring inhibition of reporter gene; can use in drugs for AIDS |
| 07/01/2003 | CA2168037C Transformation systems for the yeast candida utilis and the expression of heterologous genes therewith |
| 07/01/2003 | CA2123303C Icams immunoglobulin constant region soluble fusion proteins |
| 07/01/2003 | CA2122338C Novel human cdc25 genes, encoded products and uses therefor |
| 07/01/2003 | CA2086509C Non-cleavable soluble hybrid gp160 variant |
| 07/01/2003 | CA2080548C Monoclonal antibodies to hepatitis c virus |
| 07/01/2003 | CA2067469C Recombinant vaccine against marek's disease |
| 07/01/2003 | CA2046917C Polypeptides having thyrotropin-receptor activity, nucleic acid sequences coding for such receptors and polypeptides, and applications of these polypeptides |
| 06/26/2003 | WO2003052102A1 Specific antibody for detecting bradeion |
| 06/26/2003 | WO2003052064A2 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media |
| 06/26/2003 | WO2003052050A2 P450 enzymes, nucleic acids encoding them and methods of making and using them |
| 06/26/2003 | WO2003052048A2 Nucleic acid-associated proteins |
| 06/26/2003 | WO2003051928A1 Antibody specific for detection of bradeion |
| 06/26/2003 | WO2003051923A2 Novel g-protein coupled receptors and dna sequences thereof |
| 06/26/2003 | WO2003051921A1 Chemokine mutants acting as chemokine antagonists |
| 06/26/2003 | WO2003051720A2 A myeloma cell line useful for manufacturing recombinant proteins in chemically defined media |
| 06/26/2003 | WO2003035678A3 Sperm factor sequences |
| 06/26/2003 | WO2003004636A3 Expression vectors encoding bacteriophage signal peptides |
| 06/26/2003 | WO2002046385A3 Enzymes |
| 06/26/2003 | WO2002044406A3 Projection against mycobacterial infections |
| 06/26/2003 | WO2002016597A3 Lipid metabolism enzymes |
| 06/26/2003 | US20030121065 Polyfunctional base sequence and artificial gene containing the same |
| 06/26/2003 | US20030120058 Polypeptides; proteolysis splitting; antitumor agents |
| 06/26/2003 | US20030120054 Modified Cry3A toxins and nucleic acid sequences coding therefor |
| 06/26/2003 | US20030120053 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/26/2003 | US20030120052 Human genetic engineering; cancer diagnosis; hybrid nucleic acid |
| 06/26/2003 | US20030120051 Genetic engineering; cell differentiation of nervous system cells |
| 06/26/2003 | US20030120043 Tumor necrosis factor receptor-associated factors |
| 06/26/2003 | US20030120042 Genetic engineering; controlling folding; using reducing agent |
| 06/26/2003 | US20030120038 Inhibitor of vascular endothelial cell growth factor |
| 06/26/2003 | US20030119168 Diagnosis of anticancer agents using nucleic acids |
| 06/26/2003 | US20030119149 Fusion protein capable of forming a trimer; nonimmunogenic; modulates signaling of tumor necrosis family receptors |
| 06/26/2003 | US20030119148 Amino-terminally truncated rantes as chemokine antagonists |
| 06/26/2003 | US20030119146 Novel nucleic acids and polypeptides which resemble Rho and which interact with cell signalling pathways and proteins |
| 06/26/2003 | US20030119145 Amino acid substitutions which result in reduced hydrophobicity; use in oxidizing the terminal methyl group of a substrate to a carboxylic acid |
| 06/26/2003 | US20030119142 Of given sequence; proteins used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors |
| 06/26/2003 | US20030119141 Of given sequence; proteins used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors |
| 06/26/2003 | US20030119140 Of given sequence; proteins used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors |
| 06/26/2003 | US20030119139 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/26/2003 | US20030119138 Secreted and transmembrane polypeptides and nucleic acids encoding the same |